Metabolomics publishes current research regarding the development of technology platforms for metabolomics. This includes, but is not limited to:
- metabolomic applications within man, including pre-clinical and clinical
- pharmacometabolomics for precision medicine
- metabolic profiling and fingerprinting
- metabolite target analysis
- metabolomic applications within animals, plants and microbes
- transcriptomics and proteomics in systems biology
Metabolomics is an indispensable platform for researchers using new post-genomics approaches, to discover networks and interactions between metabolites, pharmaceuticals, SNPs, proteins and more. Its articles go beyond the genome and metabolome, by including original clinical study material together with big data from new emerging technologies.
Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2480/USD 3140/GBP 2080. VAT or local taxes will be added where applicable.
- Publishes a substantial share of the most significant current research in the metabolomics field
- Explores the application of metabolomics as related to humans, animals and plants
- Editor-in-Chief
-
- Royston Goodacre
- Publishing model
- Hybrid. Open Choice – What is this?
- Impact
- Impact factor: 3.167 (2018)
- Five year impact factor: 3.630 (2018)
- Speed
- Submission to first decision: 48 days
- Acceptance to publication: 14 days
- Usage
- Downloads: 313,901 (2018)
Articles
-
-
Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants
-
Clinical applications of breast cancer metabolomics using high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS): systematic scoping review
-
A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: a pilot study
-
Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy
Subscribe
- Subscription
- $99.00
- Note this is only the net price. Taxes will be calculated during checkout.
- Immediate online access
- Full Journal access includes all articles
- Downloadable in PDF
- Subscription expires 12/31/2019
Advertisement
About this journal
- Electronic ISSN
- 1573-3890
- Print ISSN
- 1573-3882
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- Chemical Abstracts Service (CAS)
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- EMBiology
- Gale
- Gale Academic OneFile
- Gale InfoTrac
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Natural Science Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature
